
Curaleaf accuses Aurora Cannabis of blocking its acquisition bid despite offering a 217% premium.
Curaleaf Holdings has criticized Aurora Cannabis for denying it due diligence access while allowing other potential buyers, despite Curaleaf's binding offer that includes a 217% premium on an ex-cash basis. Curaleaf argues Aurora's board is not actin...

